world
UK Ranks Low in European Prostate Cancer Survival, Expert Warns of Need for Screening
A prominent surgeon warned that the UK has high prostate cancer mortality rates compared to other European countries without a national screening program. Research presented at a conference showed that early detection through screening could improve outcomes. Political support for expanded screening has been expressed by a shadow cabinet member.
thesouthafrican.comAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
The surgeon presented data indicating that implementing a nationwide screening program could reduce mortality by enabling earlier detection.
A charity's screening initiative from 2022 to 2025 tested 12,857 men aged 40 to 80 using Prostate Specific Antigen blood tests. The program identified 183 cases of prostate cancer, with most participants showing no symptoms. Of those diagnosed, four-fifths required aggressive treatment, highlighting the potential for undetected cases without screening.
The UK diagnoses about 63,000 new prostate cancer cases each year, resulting in 13,000 deaths. Nearly half of cases are found at advanced stages, contributing to higher mortality rates. The surgeon noted that preventing one prostate cancer death requires testing 293 men, compared to 337 women for breast cancer in certain age groups.
Shadow Communities Secretary Sir James Cleverly has advocated for a national prostate cancer screening program. He stated that early treatment saves lives and improves quality of life, calling for targeted screening for high-risk groups.
“We know that early treatment not only saves lives but can completely change how men live their lives. That's why I've called for a major expansion of screening." — Sir James Cleverly Sir James Cleverly indicated plans to include the program in the Conservative Party's election manifesto.”
